Abbvie Inc
XETRA:4AB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbvie Inc
XETRA:4AB
|
US |
|
G
|
Gap Inc
F:GAP
|
US |
|
Bonduelle SA
LSE:0N75
|
FR |
|
Coveo Solutions Inc
TSX:CVO
|
CA |
|
C
|
Commerzbank AG
DUS:CBK
|
DE |
|
J
|
Japan Post Bank Co Ltd
F:5JP
|
JP |
|
Shiseido Co Ltd
TSE:4911
|
JP |
|
Crane Co
F:CZN
|
US |
|
Global Education Communities Corp
OTC:GECSF
|
CA |
|
H
|
Hisamitsu Pharmaceutical Co Inc
OTC:HTSUF
|
JP |
|
A
|
Aurubis AG
OTC:AIAGF
|
DE |
|
Z
|
Zions Bancorporation NA
DUS:ZB1
|
US |
|
Katapult Holdings Inc
NASDAQ:KPLT
|
US |
|
I
|
ING Groep NV
OTC:INGVF
|
NL |
|
A
|
Autozone Inc
LSE:0HJL
|
US |
|
Tencent Music Entertainment Group
LSE:0A2Z
|
CN |
|
Steadfast Group Ltd
OTC:SFGLF
|
AU |
|
MTR Corp Ltd
F:MRI
|
HK |
|
K
|
Kawasaki Kisen Kaisha Ltd
DUS:KLI1
|
JP |
|
G
|
General Dynamics Corp
XBER:GDX
|
US |
|
Tenaris SA
F:TW10
|
LU |
|
P
|
PDS Biotechnology Corp
F:EU6
|
US |
|
L
|
LG Electronics Inc
SWB:LGLG
|
KR |
|
T
|
Titanium Transportation Group Inc
TSX:TTNM
|
CA |
Bankruptcy Probability
Abbvie Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Abbvie Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
958.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
280.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
147.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Abbvie Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Abbvie Inc has total debt of 61.4B USD. This includes both short-term (2.5B USD) and long-term (58.9B USD) debt.
You can find a full breakdown on its Balance Sheet.
